{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T18:55:59Z","timestamp":1792090559883,"version":"4.4.0"},"reference-count":43,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,7]]},"DOI":"10.1097\/mcg.0b013e31802e7efb","type":"journal-article","created":{"date-parts":[[2007,6,14]],"date-time":"2007-06-14T05:45:27Z","timestamp":1181799927000},"page":"564-570","source":"Crossref","is-referenced-by-count":11,"title":["On-demand Treatment of Acute Heartburn With the Antacid Hydrotalcite Compared With Famotidine and Placebo"],"prefix":"10.1097","volume":"41","author":[{"given":"Wolfgang","family":"Holtmeier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerald","family":"Holtmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang F.","family":"Caspary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrike","family":"Weing\u00e4rtner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-5-20210305","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1007\/s00535-004-1440-8","article-title":"Heartburn in primary care: problems below the surface","volume":"39","author":"Holtmann","year":"2004","journal-title":"J Gastroenterol"},{"key":"R2-5-20210305","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1053\/j.gastro.2004.08.014","article-title":"The pathogenesis of heartburn in nonerosive reflux disease: a unifying hypothesis","volume":"128","author":"Barlow","year":"2005","journal-title":"Gastroenterology"},{"key":"R3-5-20210305","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s11938-005-0021-0","article-title":"Functional heartburn","volume":"8","author":"Dickman","year":"2005","journal-title":"Curr Treat Options Gastroenterol"},{"key":"R4-5-20210305","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1046\/j.1365-2036.2000.00884.x","article-title":"The prevalence of gastro-oesophageal reflux symptoms in a UK population and the consultation behaviour of patients with these symptoms","volume":"14","author":"Kennedy","year":"2000","journal-title":"Aliment Pharmacol Ther"},{"key":"R5-5-20210305","first-page":"178","article-title":"Prevalence, severity and associated features of gastro-oesophageal reflux and dyspepsia: a population-based study","volume":"113","author":"Haque","year":"2000","journal-title":"N Z Med J"},{"key":"R6-5-20210305","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.2165\/00019053-200321150-00003","article-title":"Heartburn in patients with gastro-oesophageal reflux disease in Germany and Sweden: a study on patients' burden of disease","volume":"21","author":"Jones","year":"2003","journal-title":"Pharmacoeconomics"},{"key":"R7-5-20210305","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/S0002-9343(97)00354-9","article-title":"The impact of gastroesophageal reflux disease on health-related quality of life","volume":"104","author":"Revicki","year":"1998","journal-title":"Am J Med"},{"key":"R8-5-20210305","doi-asserted-by":"crossref","first-page":"18","DOI":"10.3109\/00365529309098350","article-title":"Methodological aspects of evaluation of Quality of Life in upper gastrointestinal diseases","volume":"199","author":"Dimenas","year":"1993","journal-title":"Scand J Gastroenterol Suppl"},{"key":"R9-5-20210305","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1111\/j.1572-0241.2005.41217.x","article-title":"Updated guidelines for the diagnosis and treatment of gastroesophageal reflux disease","volume":"100","author":"DeVault","year":"2005","journal-title":"Am J Gastroenterol"},{"key":"R10-5-20210305","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/S1542-3565(04)00717-7","article-title":"PPI use in the OTC era: who to treat, with what, and for how long?","volume":"3","author":"Inadomi","year":"2005","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R11-5-20210305","first-page":"71","article-title":"Drug Ther Bull.","volume":"13","year":"1975","journal-title":""},{"key":"R12-5-20210305","first-page":"1011","article-title":"Hydrogen ion, pepsin and bile acid binding properties of hydrotalcite","volume":"49","author":"Mendelsohn","year":"1975","journal-title":"S Afr Med J"},{"key":"R13-5-20210305","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1185\/03007997909109402","article-title":"An evaluation of the bile acid binding and antacid properties of hydrotalcite in hiatus hernia and peptic ulceration","volume":"6","author":"Watters","year":"1979","journal-title":"Curr Med Res Opin"},{"key":"R14-5-20210305","article-title":"Hydrotalcite. Physicochemical characteristics of a layer-lattice antacid. Series title: Advances in Medicine","author":"Sta\u00df","year":"1988"},{"key":"R15-5-20210305","first-page":"738","article-title":"Acidity profile in humans after multiple oral administration of hydrotalcite","volume":"41","author":"Dreyer","year":"1991","journal-title":"Arzneimittelforschung"},{"key":"R16-5-20210305","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1046\/j.1443-9573.2003.00132.x","article-title":"Acid neutralization and bile acid binding capacity of hydrotalcite compared with other antacids: an in vitro study","volume":"4","author":"Miederer","year":"2003","journal-title":"Chin J Digest Dis"},{"key":"R17-5-20210305","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1097\/00045391-199508000-00006","article-title":"Effects of aluminum\/magnesium hydroxide and calcium carbonate on esophageal and gastric pH in subjects with heartburn","volume":"2","author":"Decktor","year":"1995","journal-title":"Am J Ther"},{"key":"R18-5-20210305","first-page":"717","article-title":"Therapy of benign gastric ulcer with low dose antacid hydrotalcite vs. ranitidine. Results of a double-blind, randomized multicenter trial","volume":"30","author":"Holterm\u00fcller","year":"1992","journal-title":"Z Gastroenterol"},{"key":"R19-5-20210305","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1136\/gut.35.7.896","article-title":"Antacid provides better restoration of glandular structures within the gastric ulcer scar than omeprazole","volume":"35","author":"Schmassmann","year":"1994","journal-title":"Gut"},{"key":"R20-5-20210305","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0928-4257(00)00149-2","article-title":"Antacid talcid activates in gastric mucosa genes encoding for EGF and its receptor. The molecular basis for its ulcer healing action","volume":"94","author":"Tarnawski","year":"2000","journal-title":"J Physiol Paris"},{"key":"R21-5-20210305","first-page":"953","article-title":"Einbeziehung von Call-Centern in die Patientenrekrutierung bei klinischen Pr\u00fcfungen","volume":"66","author":"Schwarz","year":"2004","journal-title":"Pharm Ind"},{"key":"R22-5-20210305","article-title":"FDA guidance for Industry: Guidelines for the clinical evaluation of gastric secretory depressant (GSD) drugs","year":"1997"},{"key":"R23-5-20210305","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1097\/00045391-199505000-00003","article-title":"Self-Directed Treatment of Intermittent Heartburn: a randomized, multicenter, double-blind, placebo-controlled evaluation of antacid and low doses of an H(2)-receptor antagonist (famotidine)","volume":"2","author":"Simon","year":"1995","journal-title":"Am J Ther"},{"key":"R24-5-20210305","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1046\/j.1365-2036.1999.00507.x","article-title":"Low-dose ranitidine for the relief of heartburn","volume":"13","author":"Pappa","year":"1999","journal-title":"Aliment Pharmacol Ther"},{"key":"R25-5-20210305","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1046\/j.1365-2036.2001.01073.x","article-title":"Effectiveness and safety of nizatidine, 75\u2009mg, for the relief of episodic heartburn","volume":"15","author":"Paul","year":"2001","journal-title":"Aliment Pharmacol Ther"},{"key":"R26-5-20210305","article-title":"The design of analgesic clinical trials","author":"Max","year":"1991"},{"key":"R27-5-20210305","doi-asserted-by":"crossref","first-page":"855","DOI":"10.2165\/00003495-199957060-00003","article-title":"Antacids revisited: a review of their clinical pharmacology and recommended therapeutic use","volume":"57","author":"Maton","year":"1999","journal-title":"Drugs"},{"key":"R28-5-20210305","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1097\/00045391-199506000-00007","article-title":"Comparative Effects of Liquid Antacids on Esophageal and Gastric pH in Patients with Heartburn","volume":"2","author":"Decktor","year":"1995","journal-title":"Am J Ther"},{"key":"R29-5-20210305","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1046\/j.1365-2036.2002.01178.x","article-title":"Effects of antacid formulation on postprandial oesophageal acidity in patients with a history of episodic heartburn","volume":"16","author":"Robinson","year":"2002","journal-title":"Aliment Pharmacol Ther"},{"key":"R30-5-20210305","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1002\/j.1552-4604.1993.tb04716.x","article-title":"Pharmacodynamics and dose-response relationship of famotidine: a double-blind randomized placebo-controlled trial","volume":"33","author":"Laskin","year":"1993","journal-title":"J Clin Pharmacol"},{"key":"R31-5-20210305","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1001\/jama.1996.03530420056036","article-title":"Comparison of the effects of over-the-counter famotidine and calcium carbonate antacid on postprandial gastric acid. A randomized controlled trial","volume":"275","author":"Feldman","year":"1996","journal-title":"JAMA"},{"key":"R32-5-20210305","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1046\/j.1365-2036.1997.113284000.x","article-title":"Prevention of heartburn relapse by low-dose famotidine: a test meal model for duration of symptom control","volume":"11","author":"Mann","year":"1997","journal-title":"Aliment Pharmacol Ther"},{"key":"R33-5-20210305","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1046\/j.1365-2036.2001.01058.x","article-title":"Synergy between low-dose ranitidine and antacid in decreasing gastric and oesophageal acidity and relieving meal-induced heartburn","volume":"15","author":"Robinson","year":"2001","journal-title":"Aliment Pharmacol Ther"},{"key":"R34-5-20210305","first-page":"385","article-title":"Placebo-efficacy and adverse effects in controlled clinical trials","volume":"49","author":"Weihrauch","year":"1999","journal-title":"Arzneimittelforschung"},{"key":"R35-5-20210305","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1136\/bmj.316.7146.1720","article-title":"Fortnightly review: treatment of gastro-oesophageal reflux disease in adults","volume":"316","author":"Galmiche","year":"1998","journal-title":"BMJ"},{"issue":"4","key":"R36-5-20210305","first-page":"iv36","article-title":"The potential role of acid suppression in functional dyspepsia: the BOND, OPERA, PILOT, and ENCORE studies","volume":"50","author":"Talley","year":"2002","journal-title":"Gut"},{"key":"R37-5-20210305","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1046\/j.1365-2036.1999.00654.x","article-title":"Onset of action during on-demand treatment with maalox suspension or low-dose ranitidine for heartburn","volume":"13","author":"Faaij","year":"1999","journal-title":"Aliment Pharmacol Ther"},{"key":"R38-5-20210305","first-page":"264","article-title":"Comparison of the effects of Rocgel and anti-H2 on the symptomatology of gastroesophageal reflux without esophagitis","volume":"31","author":"Houcke","year":"1995","journal-title":"Ann Gastroenterol Hepatol (Paris)"},{"key":"R39-5-20210305","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1097\/00007611-198603000-00017","article-title":"Effectiveness of foaming antacid in relieving induced heartburn","volume":"79","author":"Lanza","year":"1986","journal-title":"South Med J"},{"key":"R40-5-20210305","doi-asserted-by":"crossref","first-page":"401","DOI":"10.3109\/00365528909093066","article-title":"Symptomatic effect of a low-dose antacid regimen in reflux oesophagitis","volume":"24","author":"Weberg","year":"1989","journal-title":"Scand J Gastroenterol"},{"key":"R41-5-20210305","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1007\/BF01308159","article-title":"Double-blind comparison of liquid antacid and placebo in the treatment of symptomatic reflux esophagitis","volume":"28","author":"Graham","year":"1983","journal-title":"Dig Dis Sci"},{"key":"R42-5-20210305","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1055\/s-2005-857873","article-title":"Topic complex III: therapy of non-erosive reflux disease (NERD)","volume":"43","author":"Koop","year":"2005","journal-title":"Z Gastroenterol"},{"key":"R43-5-20210305","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1111\/j.1365-2036.2005.02490.x","article-title":"Systematic review: the efficacy of intermittent and on-demand therapy with histamine H2-receptor antagonists or proton pump inhibitors for gastro-oesophageal reflux disease patients","volume":"21","author":"Zacny","year":"2005","journal-title":"Aliment Pharmacol Ther"}],"container-title":["Journal of Clinical Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00004836-200707000-00005","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,10]],"date-time":"2021-04-10T06:18:38Z","timestamp":1618035518000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00004836-200707000-00005"}},"subtitle":["Randomized Double-blind Cross-over Study"],"short-title":[],"issued":{"date-parts":[[2007,7]]},"references-count":43,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2007]]}},"URL":"https:\/\/doi.org\/10.1097\/mcg.0b013e31802e7efb","relation":{},"ISSN":["0192-0790"],"issn-type":[{"value":"0192-0790","type":"print"}],"subject":[],"published":{"date-parts":[[2007,7]]}}}